The rapidly evolving landscape of cancer therapy has created unprecedented demand for assisted reproductive technologies (ART). Increasingly, oncologists are referring their patients to experts for fertility preservation. Beyond the mainstream of reproductive medicine, however, cutting edge medical and surgical technologies are being innovated to meet a spectrum of emerging patient needs. Specialists are compelled to leverage advances in in vitro maturation, oocyte and organ cryopreservation, transplantation technology, and stem cell applications. These unique and emerging topics will be addressed by the internationally recognized experts who are innovating these technologies now. Take advantage of the ample opportunities for discussion and networking, and establish your expertise. This program, designed for top level surgical and medical specialists, also facilitates full engagement by young investigators. The BioSymposia Junior Investigator Award and other awards will be given to the lead authors of the best papers in the poster session adjudicated by an expert panel.
Oocytes, Ovary and Transplantation Program Brochure
Endorsed by
The Cancer and Fertility Society
fertileHOPE